"Oxytocics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)
| Descriptor ID |
D010120
|
| MeSH Number(s) |
D27.505.696.875.737 D27.505.954.705.737
|
| Concept/Terms |
Oxytocics- Oxytocics
- Oxytocic Drugs
- Drugs, Oxytocic
- Uterine Stimulants
- Stimulants, Uterine
- Oxytocic Agents
- Agents, Oxytocic
Oxytocic Effect- Oxytocic Effect
- Effect, Oxytocic
- Oxytocic Effects
- Effects, Oxytocic
|
Below are MeSH descriptors whose meaning is more general than "Oxytocics".
Below are MeSH descriptors whose meaning is more specific than "Oxytocics".
This graph shows the total number of publications written about "Oxytocics" by people in this website by year, and whether "Oxytocics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 4 | 5 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oxytocics" by people in Profiles.
-
Optimal misoprostol dosing among patients with a body mass index greater than 30: a randomized controlled trial. Am J Obstet Gynecol. 2024 05; 230(5):565.e1-565.e16.
-
Maternal and neonatal outcomes following induction of labor for fetal growth restriction: Extra-amniotic balloon versus prostaglandins. Int J Gynaecol Obstet. 2023 Feb; 160(2):678-684.
-
Misoprostol treatment prevents hypoxia-induced cardiac dysfunction through a 14-3-3 and PKA regulatory motif on Bnip3. Cell Death Dis. 2021 11 26; 12(12):1105.
-
A comparison of cervical ripening modalities among overweight and obese nulliparous gravidas. J Matern Fetal Neonatal Med. 2020 Nov; 33(22):3804-3808.
-
An ARC-Regulated IL1?/Cox-2/PGE2/?-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML. Cancer Res. 2019 03 15; 79(6):1165-1177.
-
Management of Labor and Delivery After Fetoscopic Repair of an Open Neural Tube Defect. Obstet Gynecol. 2018 06; 131(6):1062-1068.
-
Management of Spontaneous Labor in Primigravidae: Labor Scale versus WHO Partograph (SLiP Trial) Randomized Controlled Trial. Am J Perinatol. 2018 01; 35(1):48-54.
-
The association of single-nucleotide polymorphisms in the?oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes. Am J Obstet Gynecol. 2017 09; 217(3):367.e1-367.e9.
-
Comparison of induction of labor methods for unfavorable cervices in trial of labor after cesarean delivery. J Matern Fetal Neonatal Med. 2017 May; 30(9):1010-1015.
-
Association of Cervical Effacement With the Rate of Cervical Change in Labor Among Nulliparous Women. Obstet Gynecol. 2016 Mar; 127(3):489-495.